MedPath

The effect of memantine on post-ECT cognition in depressed elderly

Phase 3
Conditions
Major Depressive Disorder.
Major depressive disorder, single episode
Registration Number
IRCT20151122025191N2
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
40
Inclusion Criteria

Diagnosis of Major Depressive Disorder
Clinical Indication for Electroconvulsive Therapy

Exclusion Criteria

Diagnosis of Dementia
Diagnosis of Delirium
Hx of Major Axis I disorder(Schizophrenia, Schizoaffective, Bipolar I,II )
Medical contraindication

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Addenbrooke's Cognitive Examination Score. Timepoint: before and 24 hour after electroconvulsive treatment. Method of measurement: Addenbrooke's Cognitive Examination-II Score.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath